Suchergebnisse - "Eliasson, Johanna"

PubPharm (21)

1

A comparison of health-related quality of life in chronic intestinal failure and end-stage kidney disease : A cross-sectional study

enthalten in: JPEN. Journal of parenteral and enteral nutrition | 2024

von Eliasson, J. | Antonsen, L. | Molsted, S. | +6

2

Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators : An exploratory analysis of the PIONEER studies

enthalten in: Diabetes, obesity & metabolism | 2024

von Rosenstock, J. | Cariou, B. | Eliasson, J. | +4

3

A comparison of health‐related quality of life in chronic intestinal failure and end‐stage kidney disease : A cross‐sectional study

enthalten in: Journal of Parenteral and Enteral Nutrition | 2024

von Eliasson, J. | Antonsen, L. | Molsted, S. | +6

4

Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2023

von Dungan, K. | Bardtrum, L. | Christiansen, E. | +4

5

Health-related quality of life in patients with primary biliary cholangitis : a cross-sectional study from a single centre in Denmark

enthalten in: Minerva gastroenterology | 2023

von Skat-Rørdam, P. | Eliasson, J. | Skalshøi Kjær, M. | +2

6

Greater Combined Reductions of $ HbA_{1c} $ ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators

enthalten in: Diabetes therapy | 2023

von Dungan, K. | Bardtrum, L. | Christiansen, E. | +4

7

Greater Combined Reductions of $ HbA_{1c} $ ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators

enthalten in: Diabetes therapy | 2023

von Dungan, K. | Bardtrum, L. | Christiansen, E. | +4

8

Greater Combined Reductions of $ HbA_{1c} $ ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators

enthalten in: Diabetes therapy | 2023

von Dungan, K. | Bardtrum, L. | Christiansen, E. | +4

9

Survey uncovering variations in the management of primary sclerosing cholangitis across Europe

enthalten in: JHEP reports : innovation in hepatology | 2022

von Eliasson, J. | Lo, B. | Schramm, C. | +4

10

Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome : An open-label phase 1 and 2 metabolic balance trial

enthalten in: JPEN. Journal of parenteral and enteral nutrition | 2022

von Eliasson, J. | Hvistendahl, M. | Freund, N. | +3